216 related articles for article (PubMed ID: 33099426)
1. Peripheral Nervous System Involvement.
Thaisetthawatkul P; Dyck PJB
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1091-1098. PubMed ID: 33099426
[TBL] [Abstract][Full Text] [Related]
2. Supportive Care for Patients with Systemic Light Chain Amyloidosis.
Wong SW; Fogaren T
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1177-1191. PubMed ID: 33099432
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.
Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Blau T; Reinhardt HC; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
J Neurol Sci; 2022 Sep; 440():120341. PubMed ID: 35872471
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular amyloidosis: Unmasking the master of disguise.
Pinto MV; Dyck PJB; Liewluck T
Muscle Nerve; 2021 Jul; 64(1):23-36. PubMed ID: 33458861
[TBL] [Abstract][Full Text] [Related]
5. Electrochemical skin conductance values suggest frequent subclinical autonomic involvement in patients with AL amyloidosis.
Montcuquet A; Duchesne M; Roussellet O; Jaccard A; Magy L
Amyloid; 2020 Sep; 27(3):215-216. PubMed ID: 32351131
[No Abstract] [Full Text] [Related]
6. Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
Mauermann ML; Clarke JO; Litchy WJ; Obici L; Lousada I; Gertz MA;
Adv Ther; 2023 Nov; 40(11):4695-4710. PubMed ID: 37658177
[TBL] [Abstract][Full Text] [Related]
7. Neuropathy Associated with Systemic Amyloidosis.
Kaku M; Berk JL
Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
[TBL] [Abstract][Full Text] [Related]
8. Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
Manwani R; Mahmood S; Sachchithanantham S; Lachmann HJ; Gillmore JD; Yong K; Rabin N; Popat R; Kyriakou C; Worthington S; Sharpley F; Smith M; Shah R; Cheesman S; Hawkins PN; Wechalekar AD
Br J Haematol; 2019 Dec; 187(5):638-641. PubMed ID: 31388995
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
10. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
Gertz MA; Dispenzieri A
JAMA; 2020 Jul; 324(1):79-89. PubMed ID: 32633805
[TBL] [Abstract][Full Text] [Related]
11. Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis.
Chompoopong P; Almarwani B; Katirji B
J Neurol Sci; 2021 Mar; 422():117336. PubMed ID: 33578240
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of systemic light chain AL amyloidosis.
Bhutani D; Lentzsch S
Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
[TBL] [Abstract][Full Text] [Related]
13. Comparing neuropathy in multiple myeloma and AL amyloidosis.
Ballegaard M; Nelson LM; Gimsing P
J Peripher Nerv Syst; 2021 Mar; 26(1):75-82. PubMed ID: 33368817
[TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal involvement with light chain amyloidosis- case series and literature review.
Vaxman I; Visram A; Pasvolsky O; Kumar S; Dispenzieri A; Buadi F; Dingli D; Lacy M; Hayman S; Kyle R; Kapoor P; Leung N; Gonsalves W; Kourelis T; Warsame R; Gertz M
Leuk Lymphoma; 2021 Feb; 62(2):316-322. PubMed ID: 33118418
[TBL] [Abstract][Full Text] [Related]
15. [AL Amyloidosis].
Ueda M
Brain Nerve; 2024 May; 76(5):583-587. PubMed ID: 38741500
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy.
Cortese A; Vegezzi E; Lozza A; Alfonsi E; Montini A; Moglia A; Merlini G; Obici L
J Neurol Neurosurg Psychiatry; 2017 May; 88(5):457-458. PubMed ID: 28188196
[No Abstract] [Full Text] [Related]
17. Systemic Amyloidosis Caused by Monoclonal Immunoglobulins: Soft Tissue and Vascular Involvement.
Hoffman JE; Dempsey NG; Sanchorawala V
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1099-1113. PubMed ID: 33099427
[TBL] [Abstract][Full Text] [Related]
18. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study.
Matsuda M; Gono T; Morita H; Katoh N; Kodaira M; Ikeda S
Eur J Neurol; 2011 Apr; 18(4):604-10. PubMed ID: 20860753
[TBL] [Abstract][Full Text] [Related]
19. Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.
Shimazaki C; Hata H; Iida S; Ueda M; Katoh N; Sekijima Y; Ikeda S; Yazaki M; Fukushima W; Ando Y
Intern Med; 2018 Jan; 57(2):181-187. PubMed ID: 29093404
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
Hasib Sidiqi M; Gertz MA
Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
